换一批REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
第一作者：
Petra,Seibold
第一单位：
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: p.seibold@dkfz-heidelberg.de.
作者：
Petra,Seibold [1]
;
Adam,Webb [2]
;
Miguel E,Aguado-Barrera [3]
;
David,Azria [4]
;
Celine,Bourgier [4]
;
Muriel,Brengues [5]
;
Erik,Briers [6]
;
Renée,Bultijnck [7]
;
Patricia,Calvo-Crespo [8]
;
Ana,Carballo [8]
;
Ananya,Choudhury [9]
;
Alessandro,Cicchetti [10]
;
Johannes,Claßen [11]
;
Elena,Delmastro [12]
;
Alison M,Dunning [13]
;
Rebecca M,Elliott [9]
;
Laura,Fachal [13]
;
Marie-Pierre,Farcy-Jacquet [14]
;
Pietro,Gabriele [12]
;
Elisabetta,Garibaldi [12]
;
Antonio,Gómez-Caamaño [15]
;
Sara,Gutiérrez-Enríquez [16]
;
Daniel S,Higginson [17]
;
Kerstie,Johnson [18]
;
Ramón,Lobato-Busto [19]
;
Meritxell,Mollà [20]
;
Anusha,Müller [21]
;
Debbie,Payne [22]
;
Paula,Peleteiro [8]
;
Giselle,Post [7]
;
Tiziana,Rancati [10]
;
Tim,Rattay [18]
;
Victoria,Reyes [20]
;
Barry S,Rosenstein [23]
;
Dirk,De Ruysscher [24]
;
Maria Carmen,De Santis [25]
;
Jörg,Schäfer [26]
;
Thomas,Schnabel [27]
;
Elena,Sperk [28]
;
R Paul,Symonds [18]
;
Hilary,Stobart [29]
;
Begoña,Taboada-Valladares [8]
;
Christopher J,Talbot [18]
;
Riccardo,Valdagni [30]
;
Ana,Vega [31]
;
Liv,Veldeman [32]
;
Tim,Ward [33]
;
Christian,Weißenberger [34]
;
Catharine M L,West [9]
;
Jenny,Chang-Claude [35]
;
REQUITE consortium
作者单位：
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: p.seibold@dkfz-heidelberg.de.
[1]
Department of Genetics and Genome Biology, University of Leicester, UK.
[2]
Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Spain.
[3]
Department of Radiation Oncology, Montpellier Cancer Institute, Université Montpellier, Inserm U1194, France.
[4]
Institut de Recherche en Cancérologie de Montpellier, Montpellier Cancer Institute, Inserm U1194, France.
[5]
Patient advocat, Hasselt, Belgium.
[6]
Department of Human Structure and Repair, Ghent University, Belgium.
[7]
Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
[8]
Translational Radiobiology Group, Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, UK.
[9]
Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[10]
Klinik für Strahlentherapie, Radiologische Onkologie und Palliativmedizin, ViDia Christliche Kliniken Karlsruhe, Germany.
[11]
Department of Radiation Oncology, Candiolo Cancer Institute - FPO, IRCCS, TO, Italy.
[12]
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Research Labs, UK.
[13]
Department of Radiation Oncology, CHU Nîmes, France.
[14]
Instituto de Investigación Sanitaria de Santiago de Compostela, Spain; Department of Radiation Oncology, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
[15]
Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
[16]
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA.
[17]
Leicester Cancer Research Centre, University of Leicester, UK.
[18]
Department of Medical Physics, Complexo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
[19]
Radiation Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
[20]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[21]
Centre for Integrated Genomic Medical Research (CIGMR), University of Manchester, UK.
[22]
Department of Radiation Oncology, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
[23]
Maastricht University Medical Center, Department of Radiation Oncology (Maastro Clinic), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands; KU Leuven, Radiation Oncology, Leuven, Belgium.
[24]
Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[25]
Strahlentherapie Speyer, Germany.
[26]
Klinik für Strahlentherapie und Radiologische Onkologie, Klinikum der Stadt Ludwigshafen gGmbH, Germany.
[27]
Department of Radiation Oncology, Universitätsklinikum Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
[28]
Independent Cancer Patients' Voice, UK.
[29]
Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Haematology-Oncology, University of Milan, Italy.
[30]
Fundación Pública Galega de Medicina Xenómica, Grupo de Medicina Xenómica (USC), Santiago de Compostela, Spain; Instituto de Investigación Sanitaria de Santiago de Compostela, Spain; Biomedical Network on Rare Diseases (CIBERER), Spain.
[31]
Department of Human Structure and Repair, Ghent University, Belgium; Department of Radiation Oncology, Ghent University Hospital, Belgium.
[32]
Trustee Pelvic Radiation Disease Association, NCRI CTRad Consumer, UK.
[33]
Zentrum für Strahlentherapie Freiburg, Germany.
[34]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Germany.
[35]
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);乳腺肿瘤(Breast Neoplasms);队列研究(Cohort Studies);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);前列腺肿瘤(Prostatic Neoplasms)
DOI
10.1016/j.radonc.2019.04.034
PMID
31146072
发布时间
2025-05-30
- 浏览0
Radiotherapy and oncology
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
